Presentation Outline ICHP Annual Meeting September 13-15
Presentation Outline ICHP Annual Meeting September 13-15
Presentation Outline ICHP Annual Meeting September 13-15
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
References<br />
• Ouellet‐Hellstrom R, Graham DJ, Staffa JA, et al. Combined hormonal contraceptives (CHCs)<br />
and the risk of cardiovascular disease endpoints. October 22, 2011.<br />
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf. Accessed August 7,<br />
2012.<br />
• Lidegaard OM, Nielsen LH, Skovlund CW, Lokkegaard E. Venous thrombosis in users of non‐<br />
oral hormonal contraception: follow‐up study, Denmark 2001‐10. BMJ. 2012;344:e2990.<br />
• Lidegaard g O, Lokkegaard g E, Jensen A, Skovlund CW, Keiding g N. Thrombotic stroke and<br />
myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257‐2266.<br />
• Sundhedsstyrelsen: Danish Health and Medicines Authority. About the register of medicinal<br />
product statistics. Updated April 12, 2012.<br />
http://laegemiddelstyrelsen.dk/en/topics/statistics,‐prices‐and‐reimbursement/statistics‐<br />
and‐analyses/about‐the‐register‐of‐medicinal‐product‐‐‐tatistics‐. Accessed August 7, 2012.<br />
• Sterling TR, Villarino E, Borisov AS, et al. Three months of rifapentine and isoniazid for latent<br />
tuberculosis infection. N Engl J Med. 2011;365(23):2<strong>15</strong>5‐2166.<br />
• American Thoracic Society, CDC. Targeted tuberculin testing and treatment of latent<br />
tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–S247. Available at<br />
http://www.cdc.gov/nchstp/tb/.<br />
References<br />
• Centers for Disease Control and Prevention. Treatment of tuberculosis: American Thoracic<br />
Society, CDC, and Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52(RR‐<br />
11):1‐80.<br />
• Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus<br />
rifampicin and isoniazid twice a week for treatment of drug‐susceptible pulmonary<br />
tuberculosis in HIV‐negative patients: a randomized clinical trial. Lancet. 2002;360(9332):528‐<br />
534.<br />
• Supplementary appendix to Three months of rifapentine and isoniazid for latent tuberculosis<br />
infection.<br />
http://www.nejm.org/doi/suppl/10.1056/NEJMoa1104875/suppl_file/nejmoa1104875_appe<br />
ndix.pdf. Accessed August 10, 2012.<br />
• The World Health Organization. WHO policy on collaborative TB/HIV activities.<br />
http://whqlibdoc.who.int/publications/2012/978924<strong>15</strong>03006_eng.pdf. Accessed August <strong>13</strong>,<br />
2012.<br />
1. Which of the following is TRUE regarding<br />
noninferiority trials?<br />
a. The standard of care is used as the active<br />
control control.<br />
b. Superiority cannot be assessed.<br />
c. Placebo is used as the control.<br />
d. Achieving noninferiority means the comparison<br />
is the same as the active control<br />
8/30/2012<br />
26
Change language